DNA Adjuvant Hydrogel‐Optimized Enzymatic Cascade Reaction for Tumor Chemodynamic‐Immunotherapy
Advanced Science · 2024-03 · 11 (10)
DOI: 10.1002/advs.202308229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 15.01.2024. Verfasst von Yan Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, 518132, China. Hauptthemen laut MEDLINE: Hydrogels, Adjuvants, Immunologic. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Universities Stable Funding Key Projects.
Abstract (Originalsprache)
Chemodynamic therapy (CDT) shows immense potential in cancer treatment as it not only directly kills tumor cells but also induces anti‐tumor immune responses. However, the efficacy of CDT is hampered by challenges in targeting CDT catalysts specifically to tumors using nanomaterials, along with the limitations of low H 2 O 2 levels and short catalyst duration within the tumor microenvironment. In this study, DNA adjuvant hydrogel to arrange a glucose oxidase‐ferrocene cascade for continuously generating reactive oxygen species (ROS) from glucose in situ for tumor CDT combined with immunotherapy is employed. By precisely tuning the catalyst spacing with DNA double helix, ROS production efficiency is elevated by up to nine times compared to free catalysts, resulting in stronger immunogenetic cell death. Upon intratumoral injection, the DNA hydrogel system elicited potent anti‐tumor immune responses, thereby effectively inhibiting established tumors and rejecting re‐challenged tumors. This work offers a novel platform for integrated CDT and immunotherapy in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, 518132, China.
- Institute of Biopharmaceutical and Health Engineering, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, 518055, China.
- Institute of Materiobiology, Department of Chemistry, College of Science, Shanghai University, Shanghai, 200444, China.
- Tsinghua-Berkeley Shenzhen Institute, Tsinghua University, Shenzhen, 518055, China.
- State Key Laboratory of Chemical Oncogenomics, Tsinghua Shenzhen International Graduate School, Tsinghua University, Shenzhen, 518055, China.
ORCID-Profile: Lele Sun
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Universities Stable Funding Key Projects
- State Key Laboratory of Chemical Oncogenomics
- Institute of Biomedical Health Technology and Engineering of Shenzhen Bay Laboratory
- GuangDong Basic and Applied Basic Research Foundation
- National Key Research and Development Program of China
Zitieren
APA
Zhao, Y., Du, J., Xu, Z., Wang, L., Ma, L., & Sun, L. (2024). DNA Adjuvant Hydrogel‐Optimized Enzymatic Cascade Reaction for Tumor Chemodynamic‐Immunotherapy. Advanced Science, 11(10). https://doi.org/10.1002/advs.202308229
Vancouver
Zhao Y, Du J, Xu Z, Wang L, Ma L, Sun L. DNA Adjuvant Hydrogel‐Optimized Enzymatic Cascade Reaction for Tumor Chemodynamic‐Immunotherapy. Advanced Science. 2024;11(10). doi:10.1002/advs.202308229
BibTeX
@article{Zhao2024,
author = {Zhao, Yan and Du, Jiangnan and Xu, Zihui and Wang, Lihua and Ma, Lan and Sun, Lele},
title = {DNA Adjuvant Hydrogel‐Optimized Enzymatic Cascade Reaction for Tumor Chemodynamic‐Immunotherapy},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {10},
doi = {10.1002/advs.202308229}
}
EUVIMED